0001209191-18-020351.txt : 20180316 0001209191-18-020351.hdr.sgml : 20180316 20180316181055 ACCESSION NUMBER: 0001209191-18-020351 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cumbo Alexander CENTRAL INDEX KEY: 0001685994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 18696954 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-15 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001685994 Cumbo Alexander 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 SVP, Chief Commercial Officer Common Stock 2018-03-15 4 M 0 241 13.71 A 23699 D Common Stock 2018-03-15 4 F 0 40 81.22 D 23659 D Common Stock 2018-03-15 4 M 0 54 13.71 A 23713 D Common Stock 2018-03-15 4 F 0 9 81.22 D 23704 D Common Stock 2018-03-15 4 M 0 835 13.90 A 24539 D Common Stock 2018-03-15 4 F 0 142 81.22 D 24397 D Common Stock 2018-03-15 4 M 0 1370 26.24 A 25767 D Common Stock 2018-03-15 4 F 0 442 81.22 D 25325 D Stock option (right to buy) 13.71 2018-03-15 4 M 0 241 0.00 D 2017-02-28 2026-02-28 Common Stock 241 1485 D Stock option (right to buy) 13.71 2018-03-15 4 M 0 54 0.00 D 2017-02-28 2026-02-28 Common Stock 54 6107 D Stock option (right to buy) 13.90 2018-03-15 4 M 0 835 0.00 D 2016-02-27 2025-02-27 Common Stock 835 5001 D Stock option (right to buy) 26.24 2018-03-15 4 M 0 1370 0.00 D 2014-01-02 2023-01-02 Common Stock 1370 11415 D The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an "option swap" enables the exercise and holding of shares of Common Stock by the Reporting Person. /s/ David Tyronne Howton, as Attorney-in-Fact for Alexander Cumbo 2018-03-16